866-997-4948(US-Canada Toll Free)

Alchemia Ltd - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 32 Pages

Alchemia Ltd - Product Pipeline Review - 2016

Summary

Global Markets Directs, Alchemia Ltd - Product Pipeline Review - 2016, provides an overview of the Alchemia Ltds pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Alchemia Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Alchemia Ltd
- The report provides overview of Alchemia Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Alchemia Ltds pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Alchemia Ltds out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Alchemia Ltds strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Alchemia Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Alchemia Ltds pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Alchemia Ltd Snapshot 5
Alchemia Ltd Overview 5
Key Facts 5
Alchemia Ltd - Research and Development Overview 6
Key Therapeutic Areas 6
Alchemia Ltd - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Alchemia Ltd - Pipeline Products Glance 11
Alchemia Ltd - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Alchemia Ltd - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Alchemia Ltd - Drug Profiles 14
HA-5FU - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
HA-Doxorubicin - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
irinotecan hydrochloride - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
Monoclonal Antibody 2 to Target CD44 for Oncology - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Small Molecules for Respiratory, Oncology, Cardiovascular, Metabolic Disorders, Infectious Disease and Neurology - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Small Molecules to Inhibit Glycosyltransferase for Bacterial Infections - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Small Molecules to Inhibit Glycosyltransferase for Gram-Positive Bacterial Infection - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Alchemia Ltd - Pipeline Analysis 24
Alchemia Ltd - Pipeline Products by Target 24
Alchemia Ltd - Pipeline Products by Route of Administration 25
Alchemia Ltd - Pipeline Products by Molecule Type 26
Alchemia Ltd - Pipeline Products by Mechanism of Action 27
Alchemia Ltd - Dormant Projects 28
Alchemia Ltd - Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
ACL-16907 29
VAST Based Drug For Obesity 29
Alchemia Ltd - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32

List of Tables
Alchemia Ltd, Key Facts 5
Alchemia Ltd - Pipeline by Indication, 2016 8
Alchemia Ltd - Pipeline by Stage of Development, 2016 9
Alchemia Ltd - Monotherapy Products in Pipeline, 2016 10
Alchemia Ltd - Phase II, 2016 11
Alchemia Ltd - Preclinical, 2016 12
Alchemia Ltd - Discovery, 2016 13
Alchemia Ltd - Pipeline by Target, 2016 24
Alchemia Ltd - Pipeline by Route of Administration, 2016 25
Alchemia Ltd - Pipeline by Molecule Type, 2016 26
Alchemia Ltd - Pipeline Products by Mechanism of Action, 2016 27
Alchemia Ltd - Dormant Developmental Projects,2016 28
Alchemia Ltd - Discontinued Pipeline Products, 2016 29
Alchemia Ltd, Subsidiaries 30

List of Figures
Alchemia Ltd - Pipeline by Top 10 Indication, 2016 7
Alchemia Ltd - Pipeline by Stage of Development, 2016 9
Alchemia Ltd - Monotherapy Products in Pipeline, 2016 10
Alchemia Ltd - Pipeline by Target, 2016 24
Alchemia Ltd - Pipeline by Molecule Type, 2016 26
Alchemia Ltd - Pipeline Products by Mechanism of Action, 2016 27

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *